AXA Framlington Biotech Fund GBP Z Acc

Register to Unlock Ratings
Performance History30/06/2021
Growth of 1,000 (GBP) Advanced Graph
AXA Framlington Biotech Fund GBP Z Acc
Fund9.7-6.419.432.71.3
+/-Cat-0.61.5-0.86.80.7
+/-B’mrk-1.4-3.2-0.910.2-6.1
 
Key Stats
NAV
30/07/2021
 GBX 471.60
Day Change -0.76%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector Specialist
ISIN GB00B784NS11
Fund Size (Mil)
31/05/2021
 GBP 417.34
Share Class Size (Mil)
30/07/2021
 GBP 347.40
Max Initial Charge -
Ongoing Charge
31/08/2020
  0.83%
Investment Objective: AXA Framlington Biotech Fund GBP Z Acc
The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Returns
Trailing Returns (GBP)30/07/2021
YTD0.02
3 Years Annualised9.01
5 Years Annualised10.57
10 Years Annualised*18.68
12 Month Yield 0.00
Management
Manager Name
Start Date
Linden Thomson
05/07/2012
Peter Hughes
01/04/2018
Inception Date
16/04/2012
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA Framlington Biotech Fund GBP Z Acc30/06/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock96.390.0096.39
Bond0.000.000.00
Property0.000.000.00
Cash3.790.523.26
Other0.350.000.35
Top 5 Regions%
United States87.79
Asia - Emerging4.56
Europe - ex Euro3.54
Eurozone2.40
United Kingdom1.71
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Regeneron Pharmaceuticals IncHealthcareHealthcare6.63
Amgen IncHealthcareHealthcare6.22
Biogen IncHealthcareHealthcare5.62
Moderna IncHealthcareHealthcare5.49
Gilead Sciences IncHealthcareHealthcare5.07
AXA Framlington Biotech Fund GBP Z Acc

Related

* This share class has performance data calculated prior to the inception date, 2012-04-16. This is based upon a simulated/extended track record, using the track record of AXA Framlington Biotech R Acc (ISIN: GB0031007254), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement